SCHEMBL10286186

SCHEMBL10286186

Cc1cc(N2CCCC2)c2c(n1)C(O)CCCC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 2/20 0.40
HSD17B10 Q99714 6/20 0.38
KDM4E B2RXH2 5/20 0.38
ALDH1A1 P00352 4/20 0.38
HPGD P15428 3/20 0.38
RECQL P46063 1/20 0.38
GBA1 P04062 1/20 0.35
UGT2B17 O75795 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
USP2 O75604 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
ACHE P22303 2/20 0.35
SLC18A3 Q16572 2/20 0.34
CRHBP P24387 1/20 0.34
CRHR2 Q13324 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPY5R Q15761 1/20 0.34
GAA P10253 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10286134 0.99 NCF1 (0.42) NCF1HSD17B10KDM4EALDH1A1HPGD
SCHEMBL527090 0.96 NCF1 (0.40) NCF1HSD17B10KDM4EALDH1A1HPGD
SCHEMBL10286133 0.82 ACHE (0.36) HSD17B10KDM4EALDH1A1HPGDUGT2B17
SCHEMBL10286333 0.81 UGT2B17 (0.45) HSD17B10KDM4EALDH1A1HPGDUGT2B17
SCHEMBL10286315 0.80 ACHE (0.39) UGT2B17ACHE
SCHEMBL10286091 0.79 HCRTR1 (0.38) HSD17B10KDM4EALDH1A1UGT2B17ACHE
SCHEMBL10286084 0.78 KDM4E (0.36) HSD17B10KDM4EALDH1A1HPGDGAA
SCHEMBL10286275 0.78 ACHE (0.40) HSD17B10KDM4EALDH1A1UGT2B17USP2
SCHEMBL10287369 0.77 ACHE (0.36) GBA1UGT2B17ACHE
SCHEMBL10286085 0.77 ACHE (0.43) HSD17B10KDM4EALDH1A1HPGDUGT2B17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130102631-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES SYNGENTA CROP PROTECTION LLC (US) 2013-04-25 US disclosed
US-20130102631-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES SYNGENTA CROP PROTECTION LLC (US) 2013-04-25 US disclosed
WO-2012001040-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2012-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130102631-A1 NOVEL MICROBIOCIDAL DIOXIME ETHER DERIVATIVES MSR1, DDT, MPO NCF1 719/4885HSD17B10 2290/4885KDM4E 1075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.